About Us
Real World Results
At the nexus of scientific research and clinical practice
Dr. Ronald J. Ruby M.D. F.A.C.E
Endocrinology
During residency at Johns Hopkins, Dr. Ruby served as chief medical resident and his fellowship training in Endocrinology at UCLA focused on diabetes, thyroid disease, and obesity. A former local chief of the medical staff, Dr. Ruby serves as the chairman of medical education, Co-chair of the Cardiometabolic Center and continues to provide leadership on the medical executive committee at Providence Little Company of Mary Medical Center, Torrance.
Dr. John P. Armato M.D.
Internal Medicine
Dr. Armato practices Internal medicine in Redondo Beach California. He is a former Chief of Staff and prior Board Chair at Providence Little Company of Mary Medical Center, Torrance, CA. Current Co-chair of the Cardiometabolic Center Dr. Armato received his medical degree from Keck School of Medicine of USC and his practice is focused on personalized strategies to prevent heart disease, diabetes and other conditions related to insulin resistance.
Publications & Abstracts
Pre-Prediabetes: Insulin Resistance is Associated with Cardiometabolic Risk in Non-obese Patients (STOP DIABETES)
Armato J, DeFronzo RA, Abdul-Ghani M, and Ruby R
J Clin Endocrinol Metab. 2024 Aug 7:dgae540. doi: 10.1210/clinem/dgae540.
Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES)
Armato J, DeFronzo RA, Abdul-Ghani M, and Ruby R
Lancet Diabetes & Endocrinology, Vol 6, Issue 10, 2018 Oct:781-789.
Plasma triglyceride determination can identify increased risk of statin-induced type 2 diabetes: A hypothesis
Armato J, Ruby RJ, and Reaven G
Atherosclerosis 239 (2015) 401-404.
Triglyceride/High Density Lipoprotein Cholesterol Concentration Ratio Identifies Accentuated Cardio-Metabolic Risk
Armato J, Ruby RJ, and Reaven G
Endocrine Practice 2015 May;21(5):495-500.
GLP-1 provoked severehypoglycemia in an individual with type 2 diabetes and a benigninsulinoma
Ruby RJ, Armato JP, Pyke C, and Peters AL
Diabetes Care 2014 Aug;37(8):e177-8.
Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction.
Armato J, DeFronzo RA, Abdul-Ghani M, Ruby R.
Endocrine Pract. 2012 May-Jun; 18(3): 342-50.
Are angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter?
Armato J, DeFronzo RA, Abdul-Ghani M, and Ruby R.
Diabetes, Obesity & Metabolism, 2022;1‐4. doi:10.1111/dom.14835.
Physiologic Response to Oral Glucose Tolerance Testing Identifies Progressors and Non-Progressors to Type 2 Diabetes in Clinical Practice (STOP DIABETES)
Armato J, DeFronzo RA, Abdul-Ghani M, and Ruby R.
Abstracts 16th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease, Endocrine Practice, Jan 2019, Vol. 25, No.1, 29A.
Ready to Get Your Life on Track?
Order your GIST™ report and gain clarity on your diabetic health risks.